Chemoimmunotherapy with inotuzumab ozogamicin combined with mini‐hyper‐CVD, with or without blinatumomab, is highly effective in patients with Philadelphia chromosome–negative acute lymphoblastic leukemia in first salvageElias Jabbour, Hagop M. Kantarjian, Koji Sasaki et al.|Cancer|2018Cited by 110
Oral decitabine and cedazuridine plus venetoclax for older or unfit patients with acute myeloid leukaemia: a phase 2 studyAlexandre Bazinet, Farhad Ravandi, Guillermo Garcia‐Manero et al.|The Lancet Haematology|2024Cited by 25
Outcomes of <i>TP53</i>-Mutant Acute Myeloid Leukemia with Venetoclax and DecitabineKunhwa Kim, Marina Konopleva, Gautam Borthakur et al.|Blood|2020Cited by 22